The global atorvastatin calcium market was valued at $298.3 million in 2023, and is projected to reach $487.8 million by 2033, growing at a CAGR of 5% from 2024 to 2033.
Report Code : A324370 | Pages : 280 | Category : Life Sciences
The global autoimmune disease testing market was valued at $5.3 billion in 2023, and is projected to reach $12.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.
Report Code : A324371 | Pages : 228 | Category : Life Sciences
The global automated biochemical analyzers market was valued at $7.6 billion in 2023, and is projected to reach $24.1 billion by 2033, growing at a CAGR of 12.2% from 2024 to 2033.
Report Code : A324373 | Pages : 228 | Category : Life Sciences
The global auto-retractable safety syringe market was valued at $3.2 billion in 2023, and is projected to reach $4.8 billion by 2033, growing at a CAGR of 4% from 2024 to 2033.
Report Code : A324374 | Pages : 216 | Category : Life Sciences
The global barbituric acid market was valued at $0.2 billion in 2023, and is projected to reach $0.3 billion by 2033, growing at a CAGR of 4% from 2024 to 2033.
Report Code : A324375 | Pages : 216 | Category : Life Sciences
The global bio pharma buffer market was valued at $1.1 billion in 2023, and is projected to reach $2.4 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
Report Code : A324376 | Pages : 280 | Category : Life Sciences
The global biofeedback instrument market was valued at $170.0 million in 2023, and is projected to reach $268.2 million by 2033, growing at a CAGR of 4.7% from 2024 to 2033.
Report Code : A324377 | Pages : 260 | Category : Life Sciences
The global bioprocess bags market was valued at $3.3 billion in 2023, and is projected to reach $14.9 billion by 2033, growing at a CAGR of 16.4% from 2024 to 2033.
Report Code : A324380 | Pages : 260 | Category : Life Sciences
The global bioresorbable medical material market was valued at $0.4 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 10.6% from 2024 to 2033.
Report Code : A324381 | Pages : 260 | Category : Life Sciences
The global bone wax market was valued at $53.1 million in 2023, and is projected to reach $73.0 million by 2033, growing at a CAGR of 3.2% from 2024 to 2033.
Report Code : A324382 | Pages : 280 | Category : Life Sciences
The global breast lesion localization methods market was valued at $1.2 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 11.7% from 2024 to 2033.
Report Code : A324384 | Pages : 280 | Category : Life Sciences
The global capnography equipment market was valued at $0.7 billion in 2023, and is projected to reach $1.7 billion by 2033, growing at a CAGR of 10.1% from 2024 to 2033.
Report Code : A324386 | Pages : 280 | Category : Life Sciences
The global cardiac care medical equipment market was valued at $50.8 billion in 2023, and is projected to reach $102.2 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.
Report Code : A324387 | Pages : 280 | Category : Life Sciences
The global cellulite reduction devices market was valued at $0.3 billion in 2023, and is projected to reach $1.0 billion by 2033, growing at a CAGR of 11.2% from 2024 to 2033.
Report Code : A324388 | Pages : 280 | Category : Life Sciences
The global chemotherapy induced peripheral neuropathy treatment market was valued at $0.9 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.
Report Code : A324389 | Pages : 280 | Category : Life Sciences
The global chromatography syringes market was valued at $81.5 million in 2023, and is projected to reach $133.3 million by 2033, growing at a CAGR of 5.1% from 2024 to 2033.
Report Code : A324390 | Pages : 280 | Category : Life Sciences
The global clinical immunoanalyzer market was valued at $4.7 billion in 2023, and is projected to reach $8.0 billion by 2033, growing at a CAGR of 5.5% from 2024 to 2033.
Report Code : A324391 | Pages : 216 | Category : Life Sciences
The global collagenase market was valued at $0.9 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 3% from 2024 to 2033.
Report Code : A324392 | Pages : 216 | Category : Life Sciences
The global conjunctivitis market was valued at $4.8 billion in 2023, and is projected to reach $7.2 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.
Report Code : A324393 | Pages : 228 | Category : Life Sciences
The global creatine market was valued at $0.2 billion in 2023, and is projected to reach $0.5 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.
Report Code : A324396 | Pages : 233 | Category : Life Sciences
The global custom antibody services market was valued at $0.6 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.
Report Code : A324397 | Pages : 233 | Category : Life Sciences
The global cystatin c assay market was valued at $367.3 million in 2023, and is projected to reach $750.7 million by 2033, growing at a CAGR of 7.4% from 2024 to 2033.
Report Code : A324398 | Pages : 233 | Category : Life Sciences
The global cytotoxic drug market was valued at $15.8 billion in 2023, and is projected to reach $19.5 billion by 2033, growing at a CAGR of 2.1% from 2024 to 2033.
Report Code : A324399 | Pages : 245 | Category : Life Sciences
The global deferiprone market was valued at $33.4 million in 2023, and is projected to reach $45.9 million by 2033, growing at a CAGR of 3.2% from 2024 to 2033.
Report Code : A324401 | Pages : 280 | Category : Life Sciences
The global demineralized allografts market was valued at $0.7 billion in 2023, and is projected to reach $1.1 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
Report Code : A324402 | Pages : 280 | Category : Life Sciences
